Infection Control Surveillance Solutions Market Size & Share 2022 to 2030
Market Size by Component (Software {On-Premise, Web-Based}, Services), by End User (Hospitals, Clinics, Specialty Centers, Ambulatory Surgical Centers) & Forecast.
Report ID: GMI5312
|
Published Date: August 2022
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Gauri Wani
Infection Control Surveillance Solutions Market Size
Infection Control Surveillance Solutions Market size surpassed USD 580 million in 2021 and is projected to expand at a CAGR of over 13% between 2022 and 2030. The prevalence of nosocomial infections will spur the global industry growth.
The increasing prevalence of nosocomial infections is among the primary factors supporting the industry expansion during the forecast period. Nosocomial infections or Healthcare-associated infections (HAI) are acquired due to prolonged stay or while undergoing treatment across hospital settings. They usually occur within 48 hours or 30 days post-discharge and may include urinary tract infections, surgical site wound infections, respiratory pneumonia, bacteremia, and gastrointestinal and skin infections, among others.
According to the Center for Disease Control and Prevention estimations under the National Healthcare Safety Network (NHSN), urinary tract infections (UTIs) are the most common and widespread hospital-associated infections. In addition, the rapid growth of the aging population and their susceptibility to such infections are likely to create new growth prospects for the infection control surveillance solutions industry in the forthcoming years.
Infection Control Surveillance Solutions Market Analysis
With respect to the component, the infection control surveillance solutions market is bifurcated into software and services. The software segment held more than USD 370 million in revenue in 2021 and is anticipated to follow a positive growth trajectory between 2022 and 2030. The segmental expansion can be credited to the emergence of several healthcare-associated infections and subsequent growth in demand for infection control software. According to the Office of Disease Prevention and Health Promotion, 1 out of every 25 hospitalized patients at any given time in the United States are affected by a healthcare-associated infection. This software help analyzes and shares real-time data and provides feedback that helps medical teams and staff mitigate and control infections more effectively, which will boost its adoption in the forthcoming years.
Based on end-use, the infection control surveillance solutions market is categorized into hospitals, clinics, ambulatory surgical centers, and specialty centers. The hospital segment accounted for more than 67% of the industry share in 2021 and is poised to register significant progress during the assessment period. The increasing burden of infectious and chronic health disorders has resulted in a growing number of people requiring frequent hospitalizations, leading to a considerable rise in hospital-acquired infections and associated healthcare expenditure. This has boosted the demand for better healthcare infrastructure resulting in the construction of new hospitals and healthcare facilities, strengthening the industry outlook.
The North America infection control surveillance solutions market constituted over 44% of the revenue share in 2021 and is likely to experience further expansion in the foreseeable future. The region has registered a noticeable rise in disposable incomes and a significant improvement in economic growth. In addition, the rising healthcare concerns have significantly pushed the healthcare expenditure across the region. North America houses several industry participants that have been focusing on introducing better and advanced products in the market, creating a pool of opportunities for the regional industry.
Infection Control Surveillance Solutions Market Share
Some of the prominent companies constituting the infection control surveillance solutions market competitive landscape include players such as
These firms have been implementing technological breakthroughs and new product development as their key growth strategy.
These advanced innovations help them improve their product offerings while offering them a competitive edge over their rival organizations. For instance, in June 2022, Premier announced the expansion of its PINC AI technology platform for clinical surveillance across long-term care facilities. The platform efficiently documents and records data about several infections and offer features such as automatic alerts, poised to broaden the company’s existing customer base.
Impact of COVID-19 Pandemic
The outbreak of the COVID-19 pandemic emerged as a boon for the infection control surveillance solutions industry. The exponential rise in COVID-positive patients and the rapidly growing rate of viral transmission resulted in the overcrowding of healthcare facilities. The increasing number of patients requiring hospitalization and critical care caused a dearth of medical staff and hospital beds, pushing the demand for appropriate infection control surveillance systems. In addition, the increasing severity of cruising and the surging morbidities and mortalities led to the growing awareness about safety, health, and hygiene, spurring the demand for infection control measures, thereby facilitating infection control surveillance systems market growth.
The infection control surveillance solutions market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030 for the following segments:
Click here to Buy Section of this Report
By Component
By End-user
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →